Sociedad Americana de Hirudoterapia

Reconstruction of circulation in the fingertip without vein repair in zone I replantation

Case series published in J Hand Surg Am (2008)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosZhang X et al. · The Journal of hand surgery, 2008

Abstract

PURPOSE: In fingertip replantation, adequate venous drainage is important for success. As the level of amputation becomes more distal, anastomosis of veins becomes more technically difficult. External bleeding is a common solution to venous congestion, but the process is burdensome because of duration of bleeding for 3 or more days after surgery. We present a new technique for reconstructing circulation without vein anastomosis in zone I replantation and analyze the outcomes of this technique in terms of eliminating external bleeding and of a high survival rate of the replanted digits. METHODS: Between 1997 and 2007, we performed 120 replantations in 112 patients (83 male and 29 female; mean age, 33 years; range, 3-54 years). All were zone I amputations, based on the Tamai classification. We surgically repaired both proper digital arteries, excluded the vein, and then ligated 1 of the arteries. Using this technique, circulation was restored. Included in the outcome evaluation were 91 digits in the 87 patients (mean age, 35 years; range, 14-54) who returned for outcome assessments 12 months after surgery. RESULTS: Of 120 digits replanted, 115 digits survived, corresponding to an overall success rate of 96%. No patients received alternative means to alleviate venous congestion, such as leeches or other means of external bleeding. Nearly all of the 87 patients (91 digits) were satisfied with the results of the replantations. CONCLUSIONS: Our technique reconstructs circulation without vein anastomosis in zone I replantation. This alternative to venous congestion involves a simple surgical procedure and straightforward postoperative care. Follow-up assessments of a series of 120 replantations show that the majority of zone I replantations led to satisfactory function. We therefore propose this technique as an effective method for zone I replantation. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdolescentAdultAmputation, TraumaticAnticoagulantsArteriesChildChild, PreschoolFemaleFinger InjuriesFingersHumansLigation

Resumen

120 zone I replantations (1997–2007) using bilateral digital artery repair plus selective artery ligation to establish circulation without vein anastomosis. 96% overall success rate; no patient required leech therapy or external bleeding for venous congestion control.

Por qué esto importa para la hirudoterapia

El estudio evaluó una técnica de reimplante de punta digital en zona I que repara ambas arterias digitales propias, excluye la vena y liga una arteria para restablecer la circulación sin anastomosis venosa. En 120 reimplantes, sobrevivieron 115 dedos, lo que supone una tasa de éxito del 96 por ciento, y ningún paciente recibió sanguijuelas ni otras medidas de sangrado externo. Esto resulta relevante para ASH porque describe explícitamente una alternativa a la terapia con sanguijuelas medicinales para la congestión venosa tras el reimplante distal. La limitación es que el artículo evalúa una técnica quirúrgica en lugar de la terapia con sanguijuelas en sí, no reporta ninguna comparación directa con el uso de sanguijuelas y aborda una población específica de amputación distal.

Citación

Reconstruction of circulation in the fingertip without vein repair in zone I replantation.

Zhang X et al. · The Journal of hand surgery, 2008

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.